In summary, while it is well recognized that E2A can be a tumor suppressor in mouse models, it is not clear whether E2A or HEB is inactivated in human T-ALL and how inactivation may occur, given the essential and dosage-dependent role of E2A and HEB in the T lineage (50–52). This evidence concerns the gene TCF12 and neoplasm.